Amicus Therapeutics, Inc. (FOLD) Tops Q4 EPS by 12c
Tweet
Share
E-mailGet Alerts FOLD Hot Sheet
Price: $10.54 --0%
Revenue Growth %: +30.2%
Financial Fact:
Interest income: 460K
Today's EPS Names:
DGICA, UXIN, TOWN, More
Revenue Growth %: +30.2%
Financial Fact:
Interest income: 460K
Today's EPS Names:
DGICA, UXIN, TOWN, More
Join SI Premium – FREE
Amicus Therapeutics, Inc. (NASDAQ: FOLD) reported Q4 EPS of ($0.25), $0.12 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $922 thousand, versus the consensus estimate of $6.06 million.
For earnings history and earnings-related data on Amicus Therapeutics, Inc. (FOLD) click here.
For earnings history and earnings-related data on Amicus Therapeutics, Inc. (FOLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Integer Holdings Corp (ITGR) Tops Q1 EPS by 2c ; Offers Guidance
- Ladder Capital (LADR) Tops Q1 EPS by 4c
- Tractor Supply (TSCO) Tops Q1 EPS by 12c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
